Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Anemia × luspatercept × Clear all

Phase

Status

Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 beta-Thalassemia 1 Leukemia, Myeloid, Acute 1 Anemia 1

Interventions

luspatercept 1 iron isomaltoside 1000 1 ferric derisomaltose 1 Radiotherapy, Intensity-Modulated 1 Population Groups 1 Pluvicto 1 Niferex 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05732961 2025-12-10

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡